Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $7.0 million.

  • Rxo's Cash from Operations rose 20000.0% to $7.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $51.0 million, marking a year-over-year increase of 52500.0%. This contributed to the annual value of $51.0 million for FY2025, which is 52500.0% up from last year.
  • Latest data reveals that Rxo reported Cash from Operations of $7.0 million as of Q4 2025, which was up 20000.0% from $23.0 million recorded in Q3 2025.
  • Rxo's Cash from Operations' 5-year high stood at $103.0 million during Q1 2022, with a 5-year trough of -$7.0 million in Q3 2024.
  • For the 5-year period, Rxo's Cash from Operations averaged around $27.9 million, with its median value being $23.0 million (2025).
  • In the last 5 years, Rxo's Cash from Operations crashed by 27500.0% in 2024 and then surged by 56000.0% in 2025.
  • Quarter analysis of 5 years shows Rxo's Cash from Operations stood at $36.0 million in 2021, then skyrocketed by 111.11% to $76.0 million in 2022, then crashed by 75.0% to $19.0 million in 2023, then plummeted by 136.84% to -$7.0 million in 2024, then surged by 200.0% to $7.0 million in 2025.
  • Its Cash from Operations was $7.0 million in Q4 2025, compared to $23.0 million in Q3 2025 and $23.0 million in Q2 2025.